Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

18 May 2023 13:38

Directorate Changes

Directorate Changes

Seneca Growth Capital VCT Plc (the "Company")

18 May 2023

Appointment of Non-Executive Director and Appointment of Chair of the Audit Committee

Non-Executive Director

The Board of Seneca Growth Capital VCT Plc is delighted to announce that Mary Anne Cordeiro was today appointed to the Board as non-executive Director of the Company. Mary Anne has also joined the Company’s Audit Committee.

Mary Anne brings to the Board extensive knowledge of both the VCT and growth capital investment sectors, having been an advisor to or executive of innovative companies in the healthcare and technology sectors for over twenty years. Mary Anne has served as a non-executive Director of Albion Technology & General VCT Plc (“AATG”) from 2013 until 2023, following its merger with Albion Income & Growth VCT Plc where she had served as a non-executive Director from 2004. Having served nine years as non-executive Director, more recently as Senior Independent Director and Chair of the Remuneration Committee, Mary Anne is retiring from the AATG Board today. Mary Anne is also the Founder and Managing Director of Science to Business Limited which specialises in advising medical technology businesses on fundraising and commercialisation strategy. Prior to this Mary Anne had a fifteen-year career in international corporate finance as a M&A Investment Banker at Goldman Sachs International Limited, Vice President at Bankers Trust Company and Managing Director of Paribas’ Financial Institutions Group. Mary Anne holds a MA (Hons) in Chemistry from the University of Oxford and is a member of the University of Oxford’s Department of Chemistry Development Board.

Mary Anne will stand for election at the Annual General Meeting of the Company to be held in 2024. There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Mary Anne.

Chair of the Audit Committee

We are also pleased to announce that further to Richard Roth’s retirement from the Board , with effect from today’s Annual General Meeting, Alex Clarkson has been appointed as Chair of the Audit Committee. Alex qualified as a Chartered Accountant with PwC in 1998 and has served as an independent non-executive Director of the Company and been a member of the Audit Committee since 2019.

These appointments are in accordance with the Board’s succession plans as outlined in the Company’s 2022 Annual Report, which was published on 21 April 2023.

Board Composition

The Board maintains its composition of four non-executive Directors, comprising three independent non-executive Directors and one representative of the Company’s Investment Manager, Seneca Partners Limited.

The Company’s Board is mindful of the new Listing Rule requirements which came into force for accounting periods starting after 1 April 2022 which require the Company to either comply with, or explain its non-compliance with, new rules intended to improve the diversity of publicly listed Boards.

The new rules seek to achieve 40% Board representation from women, one senior board position to be held by a woman and one Director to be from an ethnic minority background. Whilst the Company does not yet fully comply with the requirements, the Board will continue to work to improve the Board’s composition, providing suitable candidates possess the key skills and experience required for the position. The Board will always appoint the best person for the job. It will not discriminate on the grounds of gender, race, ethnicity, religion, sexual orientation, age or physical ability. The Board also fully supports the aims of the Hampton Alexander Report, the Parker Review and the renewed focus and emphasis on diversity in the AIC Code of Corporate Governance.

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

Date   Source Headline
19th May 20099:42 amRNSIssue of Equity
15th May 20093:27 pmRNSIssue of Equity
12th May 20097:00 amRNSInterim Management Statement
6th May 20097:00 amRNSResults of AGM and Issue of Equity
30th Apr 20097:00 amRNSTotal Voting Rights
16th Apr 20097:00 amRNSAvailability of Annual Accounts and Offer Letter
9th Apr 20091:04 pmRNSIssue of Equity-Replacement
9th Apr 200912:41 pmRNSIssue of Equity
9th Apr 200912:39 pmRNSOffer to Shareholders
6th Apr 20094:32 pmRNSDirector's Dealings
2nd Apr 20097:00 amRNSAnnual Report & Accounts and Notice of AGM
19th Nov 20089:54 amRNSDirector's Dealings
14th Nov 20081:08 pmRNSInterim Management Statement
28th Aug 20087:00 amRNSInterim Results
1st Aug 20084:00 pmRNSIssue of Equity
22nd Jul 20083:11 pmRNSResult of AGM
30th May 20083:25 pmRNSIssue of Equity
15th May 20087:00 amRNSInterim Management Statement
1st May 200810:55 amRNSIssue of Equity
8th Apr 20085:18 pmRNSAnnual Information Update
3rd Apr 20083:42 pmRNSIssue of Equity
19th Mar 20085:02 pmRNSOffer to shareholders
19th Mar 20085:02 pmRNSAnnual Report and Accounts
14th Jan 20085:22 pmRNSUpdate letter to Shareholders
3rd Jul 20063:56 pmRNSCompany Secretary Change
10th May 20062:49 pmRNSPurchase of Own Securities
26th Apr 20062:50 pmRNSChange of Name
25th Apr 20065:02 pmRNSDirector's Shareholding
20th Apr 20067:01 amRNSBVCT Update
20th Apr 20067:00 amRNSResult of AGM
10th Apr 20063:23 pmRNSDirector/PDMR Shareholding
3rd Apr 20064:28 pmRNSDirector's Shareholding
29th Mar 20061:09 pmRNSAnnual Information Update
24th Mar 20064:19 pmRNSFinal Results
9th Mar 20067:00 amRNSInvestment Process & Strategy
11th Nov 20054:33 pmRNSDirectorate Change
4th Nov 20054:04 pmRNSResult of AGM
3rd Oct 200511:19 amRNSNotice of AGM
27th Sep 20057:00 amRNSInterim Results
1st Sep 20058:31 amRNSBoard Changes
16th Aug 20055:51 pmRNSVCT Status
16th Aug 20059:09 amRNSVCT Status
2nd Aug 200510:56 amRNSBoard Change
12th Jul 20055:04 pmRNSBoard Changes
29th Apr 200510:22 amRNSFinal Results
14th Feb 20054:02 pmRNSIssue of Equity
9th Feb 20052:20 pmRNSCancellation of Listing
8th Feb 200511:27 amRNSCancellation of Listing
28th Jan 20052:55 pmRNSIssue of Equity
14th Jan 20053:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.